TLDR Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.
The study from May 1, 2017, involving 93,197 men aged 66 years or older in Ontario, Canada, found that while there was no significant increase in suicide risk associated with the use of 5α-reductase inhibitors (5ARIs) for prostatic enlargement, there was a significant increase in the risk of self-harm (HR 1.88) and incident depression (HR 1.94) during the first 18 months of treatment. After 18 months, the risk of depression remained elevated (HR 1.22), but the risk of self-harm was not significantly higher. The absolute increases in event rates were 17 per 100,000 patient-years for self-harm and 237 per 100,000 patient-years for depression. The study concluded that while the risks of self-harm and depression were higher among men taking 5ARIs, the benefits of the medication likely outweigh these risks for most patients, but discontinuation may be appropriate if psychiatric adverse effects are observed.
Cited in this study
8 / 8 results
31 citations
,
January 2018 in “American Journal of Men's Health” Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.
69 citations
,
July 2015 in “Pharmacotherapy” Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.
81 citations
,
May 2015 in “American Journal of Men's Health” Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.
73 citations
,
October 2013 in “The Journal of Sexual Medicine” Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.
44 citations
,
November 2012 in “Endocrine Practice” We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.
134 citations
,
August 2012 in “The Journal of Clinical Psychiatry” Former finasteride users with persistent sexual side effects have higher rates of depression and suicidal thoughts.
1707 citations
,
December 2003 in “The New England Journal of Medicine” Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.
88 citations
,
October 2002 in “Journal of Dermatology” Finasteride for hair loss may cause depression, affecting sleep and relationships.